| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RAB6A, member RAS oncogene family | 0.716 | 0.462 | 0.95 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
phenylalanine hydroxylase | 0.516 | 0.769 | 6.4E-23 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
prolyl 4-hydroxylase subunit beta | 0.488 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
purinergic receptor P2Y2 | 0.543 | 0.808 | 8.4E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
purinergic receptor P2Y1 | 0.551 | 0.769 | 0.52 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
purinergic receptor P2X 7 | 0.450 | 0.808 | 3.3E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
purinergic receptor P2X 5 | 0.548 | 0.769 | 2.9E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
purinergic receptor P2X 4 | 0.547 | 0.808 | 5.0E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
purinergic receptor P2X 3 | 0.565 | 0.769 | 1.0E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
purinergic receptor P2X 1 | 0.584 | 0.808 | 6.8E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
microRNA 378a | 0.532 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
2'-5'-oligoadenylate synthetase 2 | 0.670 | 0.538 | 2.6E-21 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
CCR4-NOT transcription complex subunit 2 | 0.805 | 0.269 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
nuclear transcription factor Y subunit alpha | 0.650 | 0.654 | 0.15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
T cell receptor associated transmembrane adaptor 1 | 0.615 | 0.692 | 5.6E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
sirtuin 6 | 0.496 | 0.846 | 3.9E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
solute carrier family 25 member 3 | 0.566 | 0.692 | 7.5E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
BCL2 antagonist/killer 1 | 0.555 | 0.769 | 7.4E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
regulatory associated protein of MTOR complex 1 | 0.628 | 0.692 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
sphingosine kinase 2 | 0.546 | 0.731 | 1.3E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
prion protein | 0.445 | 0.923 | 6.3E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 |